The application of insulin-like growth factor 1 (IGF-1) to the round window membrane (RWM) is an emerging treatment for inner ear diseases. RWM permeability is the key factor for efficient IGF-1 delivery. Ultrasound microbubbles (USMBs) can increase drug permeation through the RWM. In the present study, the enhancing effect of USMBs on the efficacy of IGF-1 application and the treatment effect of USMB-mediated IGF-1 delivery for noise-induced hearing loss (NIHL) were investigated. Forty-seven guinea pigs were assigned to three groups: the USM group, which received local application of recombinant human IGF-1 (rhIGF-1, 10 µg/µL) following application of USMBs to the RWM; the RWS group, which received IGF-1 application alone; and the saline-treated group. The perilymphatic concentration of rhIGF-1 in the USM group was 1.95- and 1.67- fold of that in the RWS group, 2 and 24 h after treatment, respectively. After 5 h of 118 dB SPL noise exposure, the USM group had the lowest threshold shift in auditory brainstem response, least loss of cochlear outer hair cells, and least reduction in the number of synaptic ribbons on postexposure day 28 among the three groups. The combination of USMB and IGF-1 led to a better therapeutic response to NIHL. Two hours after treatment, the USM group had significantly higher levels of Akt1 and Mapk3 gene expression than the other two groups. The most intense immunostaining for phosphor-AKT and phospho-ERK1/2 was detected in the cochlea in the USM group. These results suggested that USMB can be applied to enhance the efficacy of IGF-1 therapy in the treatment of inner ear diseases.
Objective: This study provided a quantitative prediction of best-corrected visual acuity (BCVA) for cataract patients using the inverse problem algorithm (IPA) technique earlier proposed by the authors. Methods: To this end, seven risk factors (age, BMI, MAP, IOP, HbA1c, LDL-C, and gender) were linked by a semi-empirical formula by normalizing each factor into a dimensionless range of −1.0 to +1.0. The adopted inverse problem algorithm (IPA) technique was run via a self-developed program in STATISTICA 7.0, featuring a 29-term nonlinear equation considering seven risk factors, cross-interaction between various pairs of factors, and one constant term [7 + (7 × 6)/2 + 1 = 29]. The IPA neglected quadratic, triple, or quadruple factors′ cross-interactions. This study used a dataset of 632 cataract patients to attain a reliable BCVA prediction with a variance of 0.929. A verification dataset of 160 patients with similar symptoms was used to verify this approach′s feasibility, reaching a good correlation with R2 = 0.909. Results: The verification group′s derived average AT (agreement) (9.12 ± 27.00%) indicated a slight deviation between the theoretical prediction and practical BCVA. The significant factors were age, body mass index (BMI), and intraocular pressure (IOP), whereas mean arterial pressure (MAP), hemoglobin A1c (HbA1c), low-density-lipoprotein cholesterol (LDL-C), and gender insignificantly contributed to BCVA. Conclusions: The proposed approach is instrumental in AI-assisted clinical diagnosis, yielding robust BCVA predictions for individual cataract patients based on their biological indices before the ophthalmological examination procedure.
Nicotine is a stimulant that affects the ganglia. Similar to capsaicin, it also activates sensory nerves in the airways, which leads to secretion and coughing in human subjects. The nasal mucosa can be exposed to the drug through either nasal or oral administration. The study investigated the effects of nicotine on electrically stimulated contractions of human nasal mucosa, resting tension of human nasal mucosa, and contractions induced by 10−6 M norepinephrine (NE) or 10−6 M methoxamine, a sympathetic mimetic. The purpose was to assess the direct impact of nicotine on human nasal mucosa in an in vitro laboratory setting. The findings demonstrated that the nasal mucosa contracted in a dose-dependent manner upon the addition of methoxamine to the incubation medium. Addition of nicotine at doses of 10−4 M elicited a significant relaxation response to 10–6 M methoxamine-induced mucosal strip contraction. Nicotine could inhibit electrical field stimulation-induced spike contraction and had a negligible effect on the basal tension of the nasal mucosa as the concentration increased. Adding 10−6 M nicotine to the 10−6 M NE-induced contraction, it initially induced a small reduction of the contraction, then it potentiated the contractions. This study demonstrated that high nicotine concentrations had a significant spasmolytic effect via antagonistically binding to α-adrenoceptors. Moreover, people with nasal allergies and stuffy noses who additionally utilize an α-adrenergic agonist nasal spray, oral or smoked nicotine, or both concurrently may not get relief from nasal obstruction.